RxDoctor Payments Data

Alexander Christ, MD

Surgical Oncology · Santa Monica, CANPI 1427316702

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $160,628 of the $238,937 with a category attached, or 67.2%. 19 manufacturers reported payments, led by Smith+Nephew at 27.7% of the total. 2025 is the largest year on record at $102,186, more than ten times the $690 reported in 2019. Among surgical oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$238,937in general payments, 2019–2025

Across 403 payments — averaging $592.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$66K
  • Stryker$60K
  • Globus Medical$41K
  • Zimmer Biomet$28K
  • Onkos Surgical, Inc.$19K
  • Daiichi Sankyo Inc.$14K
  • plus $11K from 13 others

What the payments were for

  • Consulting fees$160,62867%
  • Speaking & faculty fees$3,0001%
  • Travel & lodging$40,54917%
  • Food & beverage$13,7796%
  • Education$20,9819%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$238,937 in reported general payments places this provider in the 95th percentile of 209 surgical oncology providers in California.

See all surgical oncology providers in California

Medicare billing

Part B allowed, 2024
$191,727
Medicare patients
333
Services billed
710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin13$10

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →